Kaffe Bueno

Series-A
kaffebueno.com Biotech & Healthcare
Total Funding $1.3M
Latest Round Undisclosed Series-A
Last Announced Jan 22, 2024
Investors Undisclosed
Decision Makers 4 Available

About Kaffe Bueno

Unlocking the science of melanoidins — an emerging category of bioactive molecules for skin longevity, resilience and SPF performance.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website kaffebueno.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

  2. Capital Raise

    Raised $1,290,000 · Seed

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Kaffe Bueno.

Funding History

2 Rounds
Series-A equity · Jan 22, 2024
Seed equity · Nov 4, 2020

Founders & Leadership

2

Alejandro Franco

Co-founder & CCO

Work email & phone locked Unlock →

Camilo Fernandez

Co-founder & CFO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts